MDRX logo

Veradigm (MDRX) CAPEX

Annual CAPEX

$78.56 M
-$26.46 M-25.19%

December 31, 2021

Summary

Performance

1-Year Change

-25.19%

3-Year Change

-41.29%

5-Year Change

-49.96%

15-Year Change

-49.96%

MDRX CAPEX Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

85.71%
MDRX annual capital expenditures is higher than 85.71% of companies in Healthcare sector

High & Low

All-time High

$157.00 M
MDRX annual capital expenditures is currently -49.96% below its historical high of $157.00 million

3-Year Low

$78.56 M
MDRX annual capital expenditures is currently at its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2021
MDRX previous annual earnings announcement was published on Dec 31, 2021

Next Annual Earnings Report Date

N/A
MDRX next annual earnings announcement has not yet been scheduled

OtherMDRXcash flowmetrics:

Annual FCF

-$153.99 M
MDRX annual free cash flow is -$153.99 million

Annual CFO

-$75.43 M
MDRX annual cash flow from operations is -$75.43 million

Annual CFI

-$12.18 M
MDRX annual cash flow from investing activities is -$12.18 million

Annual CFF

-$258.87 M
MDRX annual cash flow from financing activities is -$258.87 million

Quarterly CAPEX

$8.17 M
-$1.79 M-17.98%

September 30, 2022

Summary

Performance

3-Month Change

-17.98%

1-Year Change

-23.51%

3-Year Change

-72.07%

5-Year Change

-72.07%

MDRX Quarterly CAPEX Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

77.06%
MDRX quarterly capital expenditures is higher than 77.06% of companies in Healthcare sector

High & Low

All-time High

$50.91 M
MDRX quarterly capital expenditures is currently -83.95% below its historical high of $50.91 million

3-Year Low

$8.17 M
MDRX quarterly capital expenditures is currently at its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2022
MDRX previous earnings announcement was published on Sep 30, 2022

Next Quarterly Earnings Report Date

N/A
MDRX next earnings announcement has not yet been scheduled

OtherMDRXcash flowmetrics:

Quarterly FCF

$19.97 M
MDRX quarterly free cash flow is $19.97 million

Quarterly CFO

$28.14 M
MDRX quarterly cash flow from operations is $28.14 million

Quarterly CFI

-$9.25 M
MDRX quarterly cash flow from investing activities is -$9.25 million

Quarterly CFF

-$38.45 M
MDRX quarterly cash flow from financing activities is -$38.45 million

TTM CAPEX

$79.00 M
-$2.51 M-3.08%

September 30, 2022

Summary

Performance

3-Month Change

-3.08%

1-Year Change

+47.58%

3-Year Change

-31.65%

5-Year Change

-31.65%

MDRX TTM CAPEX Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

83.53%
MDRX TTM capital expenditures is higher than 83.53% of companies in Healthcare sector

High & Low

All-time High

$176.54 M
MDRX TTM capital expenditures is currently -55.25% below its historical high of $176.54 million

3-Year Low

$78.56 M
MDRX TTM capital expenditures is currently +0.56% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2022
MDRX previous earnings announcement was published on Sep 30, 2022

Next Quarterly Earnings Report Date

N/A
MDRX next earnings announcement has not yet been scheduled

OtherMDRXcash flowmetrics:

TTM FCF

$81.81 M
MDRX TTM free cash flow is $81.81 million

TTM CFO

$160.81 M
MDRX TTM cash flow from operations is $160.81 million

TTM CFI

$646.42 M
MDRX TTM cash flow from investing activities is $646.42 million

TTM CFF

-$520.92 M
MDRX TTM cash flow from financing activities is -$520.92 million

MDRX CAPEX Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-25.2%-23.5%+47.6%
3 y3 years-41.3%-72.1%-31.6%
5 y5 years-50.0%-72.1%-31.6%

MDRX CAPEX Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat highat low-84.0%at low-3.1%+0.6%
5 y5-year-34.4%at low-84.0%at low-34.0%+47.6%
alltimeall time-50.0%>+9999.0%-84.0%+1340.2%-55.3%>+9999.0%

Veradigm CAPEX History

DateAnnualQuarterlyTTM
Sep 2022
-
$8.17 M(-18.0%)
$79.00 M(-3.1%)
Jun 2022
-
$9.96 M(+0.2%)
$81.51 M(+1.7%)
Mar 2022
-
$9.95 M(-80.5%)
$80.13 M(+2.0%)
Dec 2021
$78.56 M(-25.2%)
$50.91 M(+376.5%)
$78.56 M(+46.8%)
Sep 2021
-
$10.69 M(+24.4%)
$53.53 M(-19.2%)
Jun 2021
-
$8.59 M(+2.6%)
$66.29 M(-21.2%)
Mar 2021
-
$8.37 M(-67.7%)
$84.12 M(-19.9%)
Dec 2020
$105.02 M(-12.3%)
$25.88 M(+10.4%)
$105.02 M(+5.8%)
Sep 2020
-
$23.45 M(-11.3%)
$99.24 M(-10.4%)
Jun 2020
-
$26.42 M(-9.7%)
$110.81 M(-4.1%)
Mar 2020
-
$29.27 M(+45.6%)
$115.59 M(-3.5%)
Dec 2019
$119.77 M(-10.5%)
$20.10 M(-42.6%)
$119.77 M(-6.8%)
Sep 2019
-
$35.01 M(+12.2%)
$128.45 M(+1.1%)
Jun 2019
-
$31.20 M(-6.7%)
$127.09 M(-4.9%)
Mar 2019
-
$33.45 M(+16.2%)
$133.57 M(-0.2%)
Dec 2018
$133.80 M(-14.8%)
$28.78 M(-14.5%)
$133.80 M(+16.6%)
Sep 2018
-
$33.66 M(-10.7%)
$114.72 M(-12.9%)
Jun 2018
-
$37.69 M(+11.9%)
$131.74 M(-7.3%)
Mar 2018
-
$33.68 M(+247.0%)
$142.14 M(-9.5%)
Dec 2017
$157.00 M(+26.3%)
$9.71 M(-80.8%)
$157.00 M(-11.1%)
Sep 2017
-
$50.68 M(+5.4%)
$176.54 M(+5.6%)
Jun 2017
-
$48.08 M(-0.9%)
$167.16 M(+11.5%)
Mar 2017
-
$48.53 M(+66.0%)
$149.94 M(+20.6%)
Dec 2016
$124.29 M(+83.9%)
$29.25 M(-29.2%)
$124.29 M(+7.4%)
Sep 2016
-
$41.30 M(+33.9%)
$115.72 M(+28.5%)
Jun 2016
-
$30.85 M(+34.8%)
$90.03 M(+20.0%)
Mar 2016
-
$22.89 M(+10.7%)
$75.04 M(+11.0%)
Dec 2015
$67.59 M(+0.7%)
$20.68 M(+32.5%)
$67.59 M(+3.9%)
Sep 2015
-
$15.61 M(-1.6%)
$65.03 M(+3.1%)
Jun 2015
-
$15.87 M(+2.8%)
$63.08 M(+2.7%)
Mar 2015
-
$15.43 M(-14.9%)
$61.44 M(-8.4%)
Dec 2014
$67.10 M(-42.2%)
$18.13 M(+32.7%)
$67.10 M(-13.6%)
Sep 2014
-
$13.65 M(-4.1%)
$77.68 M(-10.0%)
Jun 2014
-
$14.23 M(-32.5%)
$86.31 M(-23.6%)
Mar 2014
-
$21.09 M(-26.5%)
$112.94 M(-2.8%)
Dec 2013
$116.16 M(-5.7%)
$28.71 M(+28.8%)
$116.16 M(+0.3%)
Sep 2013
-
$22.28 M(-45.5%)
$115.76 M(-5.6%)
Jun 2013
-
$40.86 M(+68.1%)
$122.63 M(+6.9%)
Mar 2013
-
$24.31 M(-14.1%)
$114.75 M(-6.8%)
Dec 2012
$123.13 M(+17.2%)
$28.31 M(-2.9%)
$123.13 M(+2.6%)
Sep 2012
-
$29.15 M(-11.6%)
$120.05 M(+0.7%)
Jun 2012
-
$32.98 M(+0.9%)
$119.22 M(+8.7%)
Mar 2012
-
$32.69 M(+29.6%)
$109.64 M(+4.4%)
Dec 2011
$105.05 M(+70.9%)
$25.22 M(-11.0%)
$105.05 M(+31.6%)
Sep 2011
-
$28.33 M(+21.1%)
$79.83 M(+55.0%)
Jun 2011
-
$23.40 M(-16.8%)
$51.50 M(+21.8%)
Mar 2011
-
$28.11 M
$42.27 M
DateAnnualQuarterlyTTM
Dec 2010
$61.49 M(+75.6%)
-
-
May 2010
-
$14.16 M(+73.2%)
$35.02 M(+67.9%)
May 2010
$35.02 M(+84.6%)
-
-
Feb 2010
-
$8.18 M(+1.2%)
$20.85 M(+64.5%)
Nov 2009
-
$8.08 M(+75.9%)
$12.68 M(+175.9%)
Aug 2009
-
$4.59 M(+13.0%)
$4.59 M(-78.5%)
May 2009
$18.97 M(-12.4%)
-
-
Sep 2008
-
$4.07 M(+0.8%)
$21.34 M(+4.9%)
Jun 2008
-
$4.04 M(-48.2%)
$20.35 M(-11.5%)
Mar 2008
-
$7.79 M(+43.0%)
$22.98 M(+6.1%)
Dec 2007
$21.66 M(+46.6%)
$5.45 M(+76.9%)
$21.66 M(+4.0%)
Sep 2007
-
$3.08 M(-53.9%)
$20.82 M(-4.6%)
Jun 2007
-
$6.67 M(+3.1%)
$21.82 M(+8.8%)
Mar 2007
-
$6.47 M(+40.4%)
$20.06 M(+35.7%)
Dec 2006
$14.78 M(+187.3%)
$4.61 M(+13.1%)
$14.78 M(+5.8%)
Sep 2006
-
$4.07 M(-17.0%)
$13.97 M(+34.1%)
Jun 2006
-
$4.91 M(+312.6%)
$10.41 M(+76.5%)
Mar 2006
-
$1.19 M(-68.6%)
$5.90 M(+14.6%)
Dec 2005
$5.14 M(-7.9%)
$3.79 M(+630.6%)
$5.14 M(-11.8%)
Sep 2005
-
$519.00 K(+31.1%)
$5.83 M(+3.5%)
Jun 2005
-
$396.00 K(-9.4%)
$5.64 M(-1.4%)
Mar 2005
-
$437.00 K(-90.2%)
$5.71 M(+2.3%)
Dec 2004
$5.58 M(+715.3%)
$4.48 M(+1287.0%)
$5.58 M(+341.5%)
Sep 2004
-
$323.00 K(-31.9%)
$1.26 M(+12.4%)
Jun 2004
-
$474.00 K(+53.9%)
$1.13 M(+45.7%)
Mar 2004
-
$308.00 K(+92.5%)
$772.00 K(+12.7%)
Dec 2003
$685.00 K(-58.6%)
$160.00 K(-12.6%)
$685.00 K(+37.8%)
Sep 2003
-
$183.00 K(+51.2%)
$497.00 K(-46.2%)
Jun 2003
-
$121.00 K(-45.2%)
$923.00 K(-41.7%)
Mar 2003
-
$221.00 K(-889.3%)
$1.58 M(-4.2%)
Dec 2002
$1.65 M(-54.6%)
-$28.00 K(-104.6%)
$1.65 M(-36.1%)
Sep 2002
-
$609.00 K(-22.1%)
$2.58 M(+96.3%)
Jun 2002
-
$782.00 K(+169.7%)
$1.32 M(-4.9%)
Mar 2002
-
$290.00 K(-67.9%)
$1.39 M(-61.9%)
Dec 2001
$3.64 M(-61.1%)
$904.00 K(-237.2%)
$3.64 M(-27.4%)
Sep 2001
-
-$659.00 K(-177.5%)
$5.01 M(-41.1%)
Jun 2001
-
$850.00 K(-66.6%)
$8.51 M(-16.2%)
Mar 2001
-
$2.54 M(+11.6%)
$10.15 M(+8.5%)
Dec 2000
$9.35 M(+112.5%)
$2.28 M(-19.7%)
$9.35 M(-5.3%)
Sep 2000
-
$2.84 M(+13.8%)
$9.87 M(+24.4%)
Jun 2000
-
$2.49 M(+42.7%)
$7.94 M(+35.8%)
Mar 2000
-
$1.75 M(-37.6%)
$5.85 M(+32.9%)
Dec 1999
$4.40 M(+450.0%)
$2.80 M(+211.1%)
$4.40 M(+175.0%)
Sep 1999
-
$900.00 K(+125.0%)
$1.60 M(+128.6%)
Jun 1999
-
$400.00 K(+33.3%)
$700.00 K(+133.3%)
Mar 1999
-
$300.00 K
$300.00 K
Dec 1998
$800.00 K
-
-

FAQ

  • What is Veradigm annual capital expenditures?
  • What is the all time high annual CAPEX for Veradigm?
  • What is Veradigm annual CAPEX year-on-year change?
  • What is Veradigm quarterly capital expenditures?
  • What is the all time high quarterly CAPEX for Veradigm?
  • What is Veradigm quarterly CAPEX year-on-year change?
  • What is Veradigm TTM capital expenditures?
  • What is the all time high TTM CAPEX for Veradigm?
  • What is Veradigm TTM CAPEX year-on-year change?

What is Veradigm annual capital expenditures?

The current annual CAPEX of MDRX is $78.56 M

What is the all time high annual CAPEX for Veradigm?

Veradigm all-time high annual capital expenditures is $157.00 M

What is Veradigm annual CAPEX year-on-year change?

Over the past year, MDRX annual capital expenditures has changed by -$26.46 M (-25.19%)

What is Veradigm quarterly capital expenditures?

The current quarterly CAPEX of MDRX is $8.17 M

What is the all time high quarterly CAPEX for Veradigm?

Veradigm all-time high quarterly capital expenditures is $50.91 M

What is Veradigm quarterly CAPEX year-on-year change?

Over the past year, MDRX quarterly capital expenditures has changed by -$2.51 M (-23.51%)

What is Veradigm TTM capital expenditures?

The current TTM CAPEX of MDRX is $79.00 M

What is the all time high TTM CAPEX for Veradigm?

Veradigm all-time high TTM capital expenditures is $176.54 M

What is Veradigm TTM CAPEX year-on-year change?

Over the past year, MDRX TTM capital expenditures has changed by +$25.47 M (+47.58%)